Lentechs Announces First Patients Enrolled in Two Milestone Clinical Trials

COLUMBUS, OH, May 18, 2021 – Lentechs, a clinical-stage ophthalmic medical device company developing a new generation of soft, suspended contact lens, designed to transform the treatment paradigm for presbyopia, today announced progress in its clinical program. The first patients have been enrolled in the Company’s milestone clinical trials LEN101 and LEN102 and fit with its investigational contact lens APIOC (pronunciation: AP•EE•OCK).

You can read the full press release here.

Shared by Tyler Stowater, board member of Lentechs LLC.